Article
Development and validation of a real-time, reverse transcription PCR assay for rapid and low-cost genotyping of hepatitis C virus genotypes 1a, 1b, 2, and 3a.
Journal of virological methods - 1 Jun 2017
Olmstead Andrea D, Lee Tracy D, Chow Ron, Gunadasa Kingsley, Auk Brian, Krajden Mel, Jassem Agatha N
Abstract excerpt
Hepatitis C virus (HCV) infection affects millions of people and leads to liver fibrosis, cirrhosis, and hepatocellular carcinoma. Treatment regimen selection requires HCV genotype (Gt) and Gt 1 subtype determination. Use of a laboratory developed, reverse transcription (RT)-PCR assay was explored as a low-cost, high-throughput screening approach for the major HCV genotypes and subtypes in North America. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
